Skip to main content
. 2017 Jun 9;16(2):1278–1288. doi: 10.3892/mmr.2017.6742

Table I.

Clinical characteristics among groups treated with varying melatonin concentrations.

Melatonin treatment group (mol/l) Age (years) Body mass index Total Gn dose (IU) Gn using days
0 27.0±2.62 20.42±1.52 1,730±400.10 11.2±1.69
10−5 27.3±3.62 21.85±3.33 1,862±541.98 12.1±2.33
10−7 27.5±3.59 22.41±2.88 2,104±533.11 12.4±2.67
10−9 28.4±3.03 21.16±2.71 1,982±453.28 10.9±1.37
10−11 27.6±3.37 22.99±2.31 2,280±420.49 12.8±2.65

n=40 per group. Gn, gonadotropin.